Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6148422
Curator's Comment: reference retrieved from https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits. | 1989-12 |
|
| Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution. | 1987-01 |
|
| Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma. | 1987 |
|
| New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent beta-adrenergic blocking properties. | 1985-07 |
|
| In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea. | 1985-04 |
|
| Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers. | 1984-10 |
| Substance Class |
Mixture
Created
by
admin
on
Edited
Mon Mar 31 23:46:18 GMT 2025
by
admin
on
Mon Mar 31 23:46:18 GMT 2025
|
| Record UNII |
733BXR9780
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
88134-91-2
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
ALTERNATIVE | |||
|
C73016
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
90581-63-8
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
C045888
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL111103
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
DTXSID301024755
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
733BXR9780
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
100000081552
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
5598
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY | |||
|
SUB07499MIG
Created by
admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |